If such a phenomenon turns out to be relevant, differently high levels of hepcidin between MDS subtypes further complicate such a finding (for details, see Section “Aspects on hepcidin, inflammation and MDS”). This evidence concerns the gene HAMP and myelodysplastic syndrome.